170 related articles for article (PubMed ID: 33219340)
1. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
Mengling T; Rall G; Bernas SN; Astreou N; Bochert S; Boelk T; Buk D; Burkard K; Endert D; Gnant K; Hildebrand S; Köksaldi H; Petit I; Sauter J; Seitz S; Stolze J; Weber K; Weber M; Lange V; Pingel J; Platz A; Schäfer T; Schetelig J; Wienand E; Geist S; Neujahr E; Schmidt AH
Bone Marrow Transplant; 2021 Apr; 56(4):798-806. PubMed ID: 33219340
[TBL] [Abstract][Full Text] [Related]
2. Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS Registry.
Schmidt AH; Sauter J; Schetelig J; Neujahr E; Pingel J
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101541. PubMed ID: 38490766
[TBL] [Abstract][Full Text] [Related]
3. A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid-19 pandemic.
Schmidt AH; Buk D; Bernas SN; Mengling T; Neujahr E; van den Brink MRM
Am J Hematol; 2021 Mar; 96(3):E91-E92. PubMed ID: 33368593
[No Abstract] [Full Text] [Related]
4. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
[TBL] [Abstract][Full Text] [Related]
5. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.
Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE
Front Immunol; 2022; 13():937900. PubMed ID: 36203566
[TBL] [Abstract][Full Text] [Related]
6. 5 years DKMS Chile: approach, results and impact of the first unrelated stem cell donor center in Chile.
Barriga F; Solloch UV; Giani A; Palma J; Wietstruck A; Sarmiento M; Carvallo C; Mosso C; Ramirez P; Sanchez M; Rojas N; Alfaro J; Saldaña S; Ende K; Flaig D; Pattillo I; Schmidt AH
Front Med (Lausanne); 2023; 10():1236506. PubMed ID: 37901400
[TBL] [Abstract][Full Text] [Related]
7. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
[TBL] [Abstract][Full Text] [Related]
8. Immunogenetics in stem cell donor registry work: The DKMS example (Part 1).
Schmidt AH; Sauter J; Baier DM; Daiss J; Keller A; Klussmeier A; Mengling T; Rall G; Riethmüller T; Schöfl G; Solloch UV; Torosian T; Means D; Kelly H; Jagannathan L; Paul P; Giani AS; Hildebrand S; Schumacher S; Markert J; Füssel M; Hofmann JA; Schäfer T; Pingel J; Lange V; Schetelig J
Int J Immunogenet; 2020 Feb; 47(1):13-23. PubMed ID: 31903698
[TBL] [Abstract][Full Text] [Related]
9. Immunogenetics in stem cell donor registry work: The DKMS example (Part 2).
Schmidt AH; Sauter J; Baier DM; Daiss J; Keller A; Klussmeier A; Mengling T; Rall G; Riethmüller T; Schöfl G; Solloch UV; Torosian T; Means D; Kelly H; Jagannathan L; Paul P; Giani AS; Hildebrand S; Schumacher S; Markert J; Füssel M; Hofmann JA; Schäfer T; Pingel J; Lange V; Schetelig J
Int J Immunogenet; 2020 Apr; 47(2):139-148. PubMed ID: 32034894
[TBL] [Abstract][Full Text] [Related]
10. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
[TBL] [Abstract][Full Text] [Related]
11. The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety.
Parmar G; Allan DS; Morris G; Dibdin N; Ganz K; Mostert K; Paulson K; Petraszko T; Stevens N; Seftel MD
Curr Oncol; 2023 Mar; 30(3):3549-3556. PubMed ID: 36975483
[TBL] [Abstract][Full Text] [Related]
12. Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
Fernandez-Sojo J; Azqueta C; Valdivia E; Martorell L; Medina-Boronat L; Martínez-Llonch N; Torrents S; Codinach M; Canals C; Elorza I; Parody R; Martino R; Trabazo M; Díaz de Heredia C; Ferra C; Valcárcel D; Linares M; Ancochea Á; García-Rey E; García-Muñoz N; Medina L; Castillo N; Carreras E; Villa J; Querol S
Bone Marrow Transplant; 2021 Oct; 56(10):2489-2496. PubMed ID: 34127808
[TBL] [Abstract][Full Text] [Related]
13. Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis.
Allan DS; Green M; Morris G; Weiss J; Dibdin N; Mercer D; Seftel M
Vox Sang; 2022 Sep; 117(9):1121-1125. PubMed ID: 35583125
[TBL] [Abstract][Full Text] [Related]
14. Aging of registered stem cell donors: implications for donor recruitment.
Schmidt AH; Biesinger L; Baier D; Harf P; Rutt C
Bone Marrow Transplant; 2008 Apr; 41(7):605-12. PubMed ID: 18071291
[TBL] [Abstract][Full Text] [Related]
15. Targeted recruitment of optimal donors for unrelated hematopoietic cell transplantation: The Stem Cell Club process.
Fingrut W; Messner HA; Allan D
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):220-231. PubMed ID: 32387075
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.
Wiercinska E; Schlipfenbacher V; Bug G; Bader P; Verbeek M; Seifried E; Bonig H
J Transl Med; 2021 Apr; 19(1):145. PubMed ID: 33832504
[TBL] [Abstract][Full Text] [Related]
17. World marrow donor association crisis response, business continuity, and disaster recovery guidelines.
Pingel J; Case C; Amer B; Hornung RA; Schmidt AH;
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1785-9. PubMed ID: 22967871
[TBL] [Abstract][Full Text] [Related]
18. Serious Stem Cell Donation Events and Recipient Adverse Reactions Related to Severe Acute Respiratory Syndrome Coronavirus 2: Review of Reports to the World Marrow Donor Association.
Pawson R; Anthias C; Cody M; Fechter M; Fournier D; O'Flaherty E; Oliviera D; van Eerden E; Mengling T
Transplant Cell Ther; 2023 Aug; 29(8):522.e1-522.e5. PubMed ID: 37271343
[TBL] [Abstract][Full Text] [Related]
19. [The Dresden Cord Blood Bank. Experiences of the Cord Blood Bank in Dresden, promoted by the German bone Marrow Donor Registry].
Ordemann R; Petzold K; Hölig K; Schaffer B; Freude M; Mauersberger S; Ehninger G
Dtsch Med Wochenschr; 2000 Nov; 125(47):1424-8. PubMed ID: 11130120
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
Othman J; Aarons D; Bajel A; Butler J; Doocey R; O'Brien T; Purtill D; Smith L; Wilcox L; Hamad N
Intern Med J; 2023 Mar; 53(3):323-329. PubMed ID: 35833788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
